Back to Search Start Over

Clinico-pathological correlation of E-cadherin expression at the invasive tumor front of Indian oral squamous cell carcinomas: An immunohistochemical study.

Authors :
Mehendiratta, Monica
Solomon, Monica Charlotte
Boaz, Karen
Guddattu, Vasudeva
Mohindra, Aashima
Source :
Journal of Oral & Maxillofacial Pathology (0973029X); May-Aug2014, Vol. 18 Issue 2, p217-222, 6p
Publication Year :
2014

Abstract

Background: Recent studies have indicated that although malignant cells at the invasive tumor front, bare morphological resemblance to the cells at central portion of the tumor, their molecular character differs significantly. E-cadherin is a cell-cell adhesion molecule that connects epithelial cells. This study attempts to correlate the E-cadherin expression at the invasive tumor front with tumor differentiation along with its clinico-pathological parameters. Materials and Methods: Immunohistochemical staining with E-cadherin was carried out on archival cases of primary oral squamous cell carcinomas (n = 30). The E-cadherin expression at the invasive tumor front was analyzed and was linked to clinico-pathological parameters including patient prognosis. Results: The downregulation of E-cadherin expression at the invasive tumor edge when compared with patient's prognosis yielded a significant correlation (P = 0.041) but its correlation with the degree of differentiation determined was not significant (P = 0.27). Also, its association with tumor size and lymph node status was negative. Conclusions: Loss of E-cadherin expression at the invasive tumor front is an important event in the progression of oral squamous cell carcinomas. Tumors with a loss of expression of E-cadherin are those which had a poor prognosis [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
0973029X
Volume :
18
Issue :
2
Database :
Complementary Index
Journal :
Journal of Oral & Maxillofacial Pathology (0973029X)
Publication Type :
Academic Journal
Accession number :
98515481
Full Text :
https://doi.org/10.4103/0973-029X.140753